Cencora, Inc.

ABG.F·Frankfurt·Healthcare
Compare
303.40+3.00 (+1.00%)today
At close: Oct 20, 3:47 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close300.40
Open299.80
Day range299.80303.40
52-week range212.90327.10
Off day high0.00%
Off 52-week high−7.25%
Volume50.00
Avg. volume (3M)1.00
Market cap57.90B
EPS (TTM)11.55
Forward P/E—
P/E ratio (TTM)26.27
Dividend yield0.69% (2.07)
Beta (5Y)0.58
Shares outstanding190.83M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin0.79%

Against its peers

Compare in full ›
ABG.F CAH 1099.HK 2784.T YI APN.JO
Market cap 57.90B 59.64B 49.24B 412.65B 27.53M 68.72B
P/E (TTM) 26.3 35.6 6.2 10.9 0.3 —
Forward P/E — 18.3 5.3 14.7 22.4 11.8
Price/book 21.3 -20.8 0.5 0.8 -0.2 0.9
Dividend yield 0.69% 0.82% 5.14% 3.07% — 1.50%
1-year change +7.75% +59.22% −21.26% +8.13% −30.84% +52.56%
Today +1.00% +1.94% +2.67% +0.19% −0.16% +2.58%

The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 20 min.

Latest news

All ABG.F news ›
@PharmaCommerce·Positive

Cencora’s Gregg Gorniak on AI After DSCSA Stabilization

Pharmaceutical Commerce Recommendations tailored to you Cencora’s Gregg Gorniak on AI After DSCSA Stabilization At LogiPharma USA 2026, Cencora’s Gregg Gorniak says DSCSA stabilization has freed up industry bandwidth to strengthen trading…

Defense World·Negative

IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $COR

IFP Advisors Inc raised its holdings in Cencora, Inc. (NYSE:COR – Free Report) by 227.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,264 shares of the…

Defense World·Positive

Cencora, Inc. $COR Stake Increased by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC grew its holdings in Cencora, Inc. (NYSE:COR – Free Report) by 235.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,336 shares…

Seeking Alpha·Positive

AI Disruption May Benefit Cencora More Than Hims & Hers

(NYSE:COR) Seeking Alpha - Cencora stands to benefit from AI-driven increases in prescription volumes as regulatory pilots expand automated prescribing. - COR’s operational leverage and AI-enabled efficiency improvements have driven…

@PharmaCommerce·Positive

Inside Cencora's Approach to AI-Driven Demand Sensing

Cencora's Matt Sample explains how AI compares forecasts with ordering patterns to flag pharma demand shifts early, with 10% forecasting gains. Artificial intelligence (AI) is giving Cencora an earlier read on shifts in pharmaceutical…

Forbes·Positive

How Cencora Turns AI Velocity Into Patient Value

Cencora operates at a scale few healthcare companies approach. The global pharmaceutical and healthcare solutions company generated $321.3 billion in fiscal 2025 revenue and supports clinical development, commercialization, distribution…

Markets Daily·Positive

Cencora, Inc. $COR Holdings Boosted by Wedmont Private Capital

Posted by Sarita Garza on Oct 10th, 2026 Wedmont Private Capital raised its position in shares of Cencora, Inc. (NYSE:COR – Free Report) by 193.8% during the 3rd quarter, Holdings Channel.com reports. The firm owned 8,320 shares of the…

From articles in the 4Search news index.

In the news

21mentions in 30 days
21with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.